FMK
Catalog No. A11423
FMK是p90核糖体蛋白S6激酶RSK1和RSK2的有效，高度特异性和不可逆的抑制剂。Fmk结合在CTKD ATP结合位点，并抑制Ser386处的RSK自磷酸化。Fmk诱导人类表达FGFR3的t（4; 14）阳性多发性骨髓瘤细胞发生明显凋亡。
- Huang-Ming Chang, .et al. FGF23 ameliorates ischemia-reperfusion induced acute kidney injury via modulation of endothelial progenitor cells: targeting SDF-1/CXCR4 signaling, Cell Death Dis, 2021, Apr 17;12(5):409 PMID: 33866326
| Catalog Num | A11423 |
|---|---|
| M. Wt | 342.37 |
| Formula | C18H19FN4O2 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 821794-92-7 |
| Synonyms | |
| SMILES | CC1=CC=C(C=C1)C2=C(N(C3=C2C(=NC=N3)N)CCCO)C(=O)CF |
FMK是p90核糖体蛋白S6激酶RSK1和RSK2的有效，高度特异性和不可逆的抑制剂。Fmk结合在CTKD ATP结合位点，并抑制Ser386处的RSK自磷酸化。Fmk诱导人类表达FGFR3的t（4; 14）阳性多发性骨髓瘤细胞发生明显凋亡。
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 29.21 mL | 146.04 mL | 292.08 mL |
| 0.5 mM | 5.84 mL | 29.21 mL | 58.42 mL |
| 1 mM | 2.92 mL | 14.6 mL | 29.21 mL |
| 5 mM | 0.58 mL | 2.92 mL | 5.84 mL |
*The above data is based on the productmolecular weight 342.37. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.